Machine learning model can predict postoperative complications in children up to 3 days before a formal diagnosis.

Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes.

HealthDay News — DropScreen (DS) and ViewAllergy39 (VA) are not equally effective for detecting specific immunoglobulin (Ig) E involved in pollinosis, according to a study recently published online in ...

The USPSTF meets several times a year to review the latest science and decide which screenings, medications and other preventive services should be fully covered by insurance.

The single-arm, open-label DR-OVP-002 study is currently evaluating Ovaprene in sexually active women aged 18 to 40 years who are at risk for pregnancy or desiring contraception.

Baxdrostat is an investigational highly selective, oral, small molecule designed to inhibit aldosterone synthase.

FirstLight and RadiantLight evaluated the safety and efficacy of oveporexton for the treatment of narcolepsy with cataplexy in participants aged 16 to 70 years old.

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

The Food and Drug Administration (FDA) has accepted the New Drug Application for doravirine/islatravir (DOR/ISL) for adults with virologically-suppressed HIV-1 infection.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).